epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Aristada

aripiprazole lauroxil

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Dementia-Related Psychosis

not approved for dementia-related psychosis; incr. mortality risk in elderly patients on antipsychotic tx for dementia-related psychosis; most deaths due to cardiovascular or infectious events

Adult Dosing .

Dosage forms:  INJ (pre-filled syringe): 441 mg per 1.6 mL, 662 mg per 2.4 mL, 882 mg per 3.2 mL, 1064 mg per 3.9 mL

Special Note

[equivalency or interchangeability info]
Info: Aristada not interchangeable with Aristada Initio due to different pharmacokinetic profiles

schizophrenia

[qmo dosing regimen]
Dose: 441-882 mg IM qmo; Start: may give 1st dose within 10 days of concurrent Aristada Initio and aripiprazole 30 mg PO x1, otherwise overlap PO aripiprazole x21 days; Info: for patients stable on PO aripiprazole; see pkg insert for conversion from PO aripiprazole and for missed dose recommendations; space doses at least 14 days apart; decr. dose in CYP2D6 poor metabolizers; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[q6wk dosing regimen]
Dose: 882 mg IM q6wk; Start: may give 1st dose within 10 days of concurrent Aristada Initio and aripiprazole 30 mg PO x1, otherwise overlap PO aripiprazole x21 days; Info: for patients stable on PO aripiprazole; see pkg insert for conversion from PO aripiprazole and for missed dose recommendations; space doses at least 14 days apart; decr. dose in CYP2D6 poor metabolizers; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[q2mo dosing regimen]
Dose: 1064 mg IM q2mo; Start: may give 1st dose within 10 days of concurrent Aristada Initio and aripiprazole 30 mg PO x1, otherwise overlap PO aripiprazole x21 days; Info: for patients stable on PO aripiprazole; see pkg insert for conversion from PO aripiprazole and for missed dose recommendations; space doses at least 14 days apart; decr. dose in CYP2D6 poor metabolizers; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC

renal dosing

[see below]
CrCl >15: no adjustment; CrCl <15: not defined
HD/PD: not defined

hepatic dosing

[no adjustment]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@655398d0
  • hypersensitivity to drug or ingredient
  • caution: CYP2D6 poor metabolizers
  • caution: elderly patients
  • caution: psychosis, dementia-associated
  • caution: cerebrovascular disease
  • caution: cardiovascular disease
  • caution: MI history
  • caution: ischemic heart disease
  • caution: heart failure
  • caution: hypovolemia
  • caution: dehydration
  • caution: hypotension
  • caution: aspiration pneumonia risk
  • caution: seizure history
  • caution: seizure risk
  • caution: diabetes mellitus
  • caution: diabetes mellitus risk
  • caution: environmental temperature, high
  • caution: leukopenia
  • caution: neutropenia
  • caution: leukopenia history, drug-induced
  • caution: neutropenia history, drug-induced

Drug Interactions .

Overview

aripiprazole lauroxil

atypical antipsychotic

Interaction Characteristics:
  • CYP2D6 substrate
  • CYP3A4 substrate
  • CNS depression
  • decreases central histamine effects
  • extrapyramidal effects
  • hyperglycemic effects
  • hyperthermia
  • hypotensive effects
  • lowers seizure threshold
Other Info
  • drug interactions apply only to Aristada and Aristada Initio (aripiprazole lauroxil, injectable prodrug of aripiprazole); see other aripiprazole products for potentially relevant interactions
  • aripiprazole is a substrate of CYP2D6 and CYP3A4; drug interaction guidance may vary with CYP450 inhibitors if patient is CYP2D6 poor metabolizer (PM)
  • avoid combo with Aristada Initio if also combined with strong CYP2D6 inhibitor, strong CYP3A4 inhibitor and/or major CYP3A4 inducer as dose adjustment not possible; Aristada Initio not interchangeable with Aristada due to different pharmacokinetic profiles

Avoid/Use Alternative

  • acebutolol
  • Aristada (aripiprazole lauroxil)
    +
    acebutolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + acebutolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • adagrasib
  • Aristada (aripiprazole lauroxil)
    +
    adagrasib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + adagrasib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • aldesleukin
  • Aristada (aripiprazole lauroxil)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aldesleukin

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, severe or life-threatening hypotension (including orthostasis), seizures (additive effects)

  • aliskiren
  • Aristada (aripiprazole lauroxil)
    +
    aliskiren
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aliskiren

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • alprazolam
  • Aristada (aripiprazole lauroxil)
    +
    alprazolam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + alprazolam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • amifampridine
  • Aristada (aripiprazole lauroxil)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + amifampridine

    consider alternative: combo may incr. risk of seizures (additive effects)

  • amiloride
  • Aristada (aripiprazole lauroxil)
    +
    amiloride
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + amiloride

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amlodipine
  • Aristada (aripiprazole lauroxil)
    +
    amlodipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + amlodipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • apalutamide
  • Aristada (aripiprazole lauroxil)
    +
    apalutamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + apalutamide

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • aprocitentan
  • Aristada (aripiprazole lauroxil)
    +
    aprocitentan
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aprocitentan

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole bimonthly injection
  • Aristada (aripiprazole lauroxil)
    +
    aripiprazole bimonthly injection
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aripiprazole bimonthly injection

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole lauroxil
  • Aristada (aripiprazole lauroxil)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aripiprazole lauroxil

    avoid combo after tx initiation: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole monthly injection
  • Aristada (aripiprazole lauroxil)
    +
    aripiprazole monthly injection
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aripiprazole monthly injection

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole oral
  • Aristada (aripiprazole lauroxil)
    +
    aripiprazole oral
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + aripiprazole oral

    avoid combo after tx initiation: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • asenapine
  • Aristada (aripiprazole lauroxil)
    +
    asenapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + asenapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • atazanavir
  • Aristada (aripiprazole lauroxil)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + atazanavir

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • atenolol
  • Aristada (aripiprazole lauroxil)
    +
    atenolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + atenolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • azilsartan medoxomil
  • Aristada (aripiprazole lauroxil)
    +
    azilsartan medoxomil
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + azilsartan medoxomil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • benazepril
  • Aristada (aripiprazole lauroxil)
    +
    benazepril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + benazepril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol
  • Aristada (aripiprazole lauroxil)
    +
    betaxolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + betaxolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bisoprolol
  • Aristada (aripiprazole lauroxil)
    +
    bisoprolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + bisoprolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • brexpiprazole
  • Aristada (aripiprazole lauroxil)
    +
    brexpiprazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + brexpiprazole

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • bumetanide
  • Aristada (aripiprazole lauroxil)
    +
    bumetanide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + bumetanide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupropion
  • Aristada (aripiprazole lauroxil)
    +
    bupropion
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + bupropion

    ARISTADA INITIO: avoid combo; ARISTADA: consider lower bupropion doses; if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of seizures, other adverse effects (hepatic metabolism inhibited; additive effects)

  • butalbital
  • Aristada (aripiprazole lauroxil)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + butalbital

    avoid combo: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • candesartan cilexetil
  • Aristada (aripiprazole lauroxil)
    +
    candesartan cilexetil
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + candesartan cilexetil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • captopril
  • Aristada (aripiprazole lauroxil)
    +
    captopril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + captopril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • carbamazepine
  • Aristada (aripiprazole lauroxil)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + carbamazepine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP; if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment, hypotension, including syncope; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • cariprazine
  • Aristada (aripiprazole lauroxil)
    +
    cariprazine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + cariprazine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • carvedilol
  • Aristada (aripiprazole lauroxil)
    +
    carvedilol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + carvedilol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ceritinib
  • Aristada (aripiprazole lauroxil)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ceritinib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • chloramphenicol
  • Aristada (aripiprazole lauroxil)
    +
    chloramphenicol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + chloramphenicol

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • chlordiazepoxide
  • Aristada (aripiprazole lauroxil)
    +
    chlordiazepoxide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + chlordiazepoxide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • chlorothiazide
  • Aristada (aripiprazole lauroxil)
    +
    chlorothiazide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + chlorothiazide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorthalidone
  • Aristada (aripiprazole lauroxil)
    +
    chlorthalidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + chlorthalidone

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clarithromycin
  • Aristada (aripiprazole lauroxil)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clarithromycin

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • clevidipine
  • Aristada (aripiprazole lauroxil)
    +
    clevidipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clevidipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clobazam
  • Aristada (aripiprazole lauroxil)
    +
    clobazam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clobazam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • clonazepam
  • Aristada (aripiprazole lauroxil)
    +
    clonazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clonazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • clonidine
  • Aristada (aripiprazole lauroxil)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clonidine

    if ADHD use, avoid combo; otherwise, monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • clorazepate
  • Aristada (aripiprazole lauroxil)
    +
    clorazepate
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clorazepate

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • clozapine
  • Aristada (aripiprazole lauroxil)
    +
    clozapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + clozapine

    use alternative or monitor BP, HR: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, seizures, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • cobicistat
  • Aristada (aripiprazole lauroxil)
    +
    cobicistat
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + cobicistat

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • codeine
  • Aristada (aripiprazole lauroxil)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + codeine

    avoid combo if antitussive use; otherwise, monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • dacomitinib
  • Aristada (aripiprazole lauroxil)
    +
    dacomitinib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + dacomitinib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • diazepam
  • Aristada (aripiprazole lauroxil)
    +
    diazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + diazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • diltiazem
  • Aristada (aripiprazole lauroxil)
    +
    diltiazem
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + diltiazem

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • doxazosin
  • Aristada (aripiprazole lauroxil)
    +
    doxazosin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + doxazosin

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxylamine
  • Aristada (aripiprazole lauroxil)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting, otherwise caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • enalapril
  • Aristada (aripiprazole lauroxil)
    +
    enalapril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + enalapril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalaprilat
  • Aristada (aripiprazole lauroxil)
    +
    enalaprilat
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + enalaprilat

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • encorafenib
  • Aristada (aripiprazole lauroxil)
    +
    encorafenib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + encorafenib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Aristada (aripiprazole lauroxil)
    +
    enzalutamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + enzalutamide

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • eplerenone
  • Aristada (aripiprazole lauroxil)
    +
    eplerenone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + eplerenone

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • esmolol
  • Aristada (aripiprazole lauroxil)
    +
    esmolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + esmolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • estazolam
  • Aristada (aripiprazole lauroxil)
    +
    estazolam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + estazolam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • ethacrynic acid
  • Aristada (aripiprazole lauroxil)
    +
    ethacrynic acid
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ethacrynic acid

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ethanol (alcoholic beverage)
  • Aristada (aripiprazole lauroxil)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ethanol (alcoholic beverage)

    avoid combo: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • ethanol injection
  • Aristada (aripiprazole lauroxil)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ethanol injection

    use alternative or monitor respiratory rate, BP: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • felodipine
  • Aristada (aripiprazole lauroxil)
    +
    felodipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + felodipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fenoldopam
  • Aristada (aripiprazole lauroxil)
    +
    fenoldopam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + fenoldopam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fluoxetine
  • Aristada (aripiprazole lauroxil)
    +
    fluoxetine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + fluoxetine

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • flurazepam
  • Aristada (aripiprazole lauroxil)
    +
    flurazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + flurazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • fosinopril
  • Aristada (aripiprazole lauroxil)
    +
    fosinopril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + fosinopril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fosphenytoin
  • Aristada (aripiprazole lauroxil)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + fosphenytoin

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • furosemide
  • Aristada (aripiprazole lauroxil)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + furosemide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • haloperidol
  • Aristada (aripiprazole lauroxil)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + haloperidol

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hypotension, including orthostasis (additive effects)

  • hydralazine
  • Aristada (aripiprazole lauroxil)
    +
    hydralazine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + hydralazine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrochlorothiazide
  • Aristada (aripiprazole lauroxil)
    +
    hydrochlorothiazide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + hydrochlorothiazide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrocodone
  • Aristada (aripiprazole lauroxil)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + hydrocodone

    avoid combo if antitussive use; otherwise, monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • idelalisib
  • Aristada (aripiprazole lauroxil)
    +
    idelalisib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + idelalisib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • iloperidone
  • Aristada (aripiprazole lauroxil)
    +
    iloperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + iloperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • indapamide
  • Aristada (aripiprazole lauroxil)
    +
    indapamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + indapamide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • irbesartan
  • Aristada (aripiprazole lauroxil)
    +
    irbesartan
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + irbesartan

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isocarboxazid
  • Aristada (aripiprazole lauroxil)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + isocarboxazid

    use alternative during and x10 days after isocarboxazid use: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • isradipine
  • Aristada (aripiprazole lauroxil)
    +
    isradipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + isradipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • itraconazole
  • Aristada (aripiprazole lauroxil)
    +
    itraconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + itraconazole

    ARISTADA INITIO: avoid combo during and x2wk after itraconazole tx; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ivosidenib
  • Aristada (aripiprazole lauroxil)
    +
    ivosidenib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ivosidenib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • kava
  • Aristada (aripiprazole lauroxil)
    +
    kava
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + kava

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • ketoconazole
  • Aristada (aripiprazole lauroxil)
    +
    ketoconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ketoconazole

    ARISTADA INITIO: avoid combo during and up to 1wk after ketoconazole use; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 poor metabolizer, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • kratom
  • Aristada (aripiprazole lauroxil)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + kratom

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • labetalol
  • Aristada (aripiprazole lauroxil)
    +
    labetalol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + labetalol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levoketoconazole
  • Aristada (aripiprazole lauroxil)
    +
    levoketoconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + levoketoconazole

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • lisinopril
  • Aristada (aripiprazole lauroxil)
    +
    lisinopril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lisinopril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lofexidine
  • Aristada (aripiprazole lauroxil)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lofexidine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • lonafarnib
  • Aristada (aripiprazole lauroxil)
    +
    lonafarnib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lonafarnib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • lorazepam
  • Aristada (aripiprazole lauroxil)
    +
    lorazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lorazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • losartan
  • Aristada (aripiprazole lauroxil)
    +
    losartan
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + losartan

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lumacaftor/ivacaftor
  • Aristada (aripiprazole lauroxil)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lumacaftor/ ivacaftor

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • lumateperone
  • Aristada (aripiprazole lauroxil)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lumateperone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • lurasidone
  • Aristada (aripiprazole lauroxil)
    +
    lurasidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + lurasidone

    use alternative or monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • mavorixafor
  • Aristada (aripiprazole lauroxil)
    +
    mavorixafor
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + mavorixafor

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • metaxalone
  • Aristada (aripiprazole lauroxil)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + metaxalone

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • methyldopa
  • Aristada (aripiprazole lauroxil)
    +
    methyldopa
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + methyldopa

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • metoclopramide
  • Aristada (aripiprazole lauroxil)
    +
    metoclopramide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + metoclopramide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, neuroleptic malignant syndrome, extrapyramidal symptoms (additive effects)

  • metolazone
  • Aristada (aripiprazole lauroxil)
    +
    metolazone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + metolazone

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metoprolol
  • Aristada (aripiprazole lauroxil)
    +
    metoprolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + metoprolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • midazolam
  • Aristada (aripiprazole lauroxil)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + midazolam

    ARISTADA INITIO: avoid combo; ARISTADA: use alternative or monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • mifepristone
  • Aristada (aripiprazole lauroxil)
    +
    mifepristone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + mifepristone

    ALL FORMS: actions apply during and x14 days after daily mifepristone; ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • milsaperidone
  • Aristada (aripiprazole lauroxil)
    +
    milsaperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + milsaperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • minoxidil
  • Aristada (aripiprazole lauroxil)
    +
    minoxidil
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + minoxidil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mitotane
  • Aristada (aripiprazole lauroxil)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + mitotane

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • moexipril
  • Aristada (aripiprazole lauroxil)
    +
    moexipril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + moexipril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nadolol
  • Aristada (aripiprazole lauroxil)
    +
    nadolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nadolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nebivolol
  • Aristada (aripiprazole lauroxil)
    +
    nebivolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nebivolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nefazodone
  • Aristada (aripiprazole lauroxil)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nefazodone

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • nelfinavir
  • Aristada (aripiprazole lauroxil)
    +
    nelfinavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nelfinavir

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • nicardipine
  • Aristada (aripiprazole lauroxil)
    +
    nicardipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nicardipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nifedipine
  • Aristada (aripiprazole lauroxil)
    +
    nifedipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nifedipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nimodipine
  • Aristada (aripiprazole lauroxil)
    +
    nimodipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nimodipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nisoldipine
  • Aristada (aripiprazole lauroxil)
    +
    nisoldipine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + nisoldipine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • olanzapine
  • Aristada (aripiprazole lauroxil)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + olanzapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • olmesartan medoxomil
  • Aristada (aripiprazole lauroxil)
    +
    olmesartan medoxomil
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + olmesartan medoxomil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oxazepam
  • Aristada (aripiprazole lauroxil)
    +
    oxazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + oxazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • oxybate
  • Aristada (aripiprazole lauroxil)
    +
    oxybate
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + oxybate

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • paliperidone
  • Aristada (aripiprazole lauroxil)
    +
    paliperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + paliperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • paroxetine
  • Aristada (aripiprazole lauroxil)
    +
    paroxetine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + paroxetine

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • pentobarbital
  • Aristada (aripiprazole lauroxil)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + pentobarbital

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP; if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (hepatic metabolism induced; additive effects)

  • perindopril
  • Aristada (aripiprazole lauroxil)
    +
    perindopril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + perindopril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenelzine
  • Aristada (aripiprazole lauroxil)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + phenelzine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Aristada (aripiprazole lauroxil)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + phenobarbital

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP; if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • phenoxybenzamine
  • Aristada (aripiprazole lauroxil)
    +
    phenoxybenzamine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + phenoxybenzamine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentolamine
  • Aristada (aripiprazole lauroxil)
    +
    phentolamine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + phentolamine

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenytoin
  • Aristada (aripiprazole lauroxil)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + phenytoin

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • pindolol
  • Aristada (aripiprazole lauroxil)
    +
    pindolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + pindolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pitolisant
  • Aristada (aripiprazole lauroxil)
    +
    pitolisant
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + pitolisant

    avoid combo: combo may decr. pitolisant efficacy (antagonistic effects)

  • posaconazole
  • Aristada (aripiprazole lauroxil)
    +
    posaconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + posaconazole

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • prazosin
  • Aristada (aripiprazole lauroxil)
    +
    prazosin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + prazosin

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • primidone
  • Aristada (aripiprazole lauroxil)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + primidone

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate; if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • promethazine
  • Aristada (aripiprazole lauroxil)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + promethazine

    use alternative or monitor respiratory rate, BP; decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, seizures, hyperthermia, extrapyramidal symptoms, hypotension, including orthostasis (additive effects)

  • propranolol
  • Aristada (aripiprazole lauroxil)
    +
    propranolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + propranolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quazepam
  • Aristada (aripiprazole lauroxil)
    +
    quazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + quazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • quetiapine
  • Aristada (aripiprazole lauroxil)
    +
    quetiapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + quetiapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • quinapril
  • Aristada (aripiprazole lauroxil)
    +
    quinapril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + quinapril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quinidine (antiarrhythmic)
  • Aristada (aripiprazole lauroxil)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + quinidine (antiarrhythmic)

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • quinidine (CYP2D6 inhibitor)
  • Aristada (aripiprazole lauroxil)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + quinidine (CYP2D6 inhibitor)

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ramipril
  • Aristada (aripiprazole lauroxil)
    +
    ramipril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ramipril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • remimazolam
  • Aristada (aripiprazole lauroxil)
    +
    remimazolam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + remimazolam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of hypotension (including orthostasis), profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • ribociclib
  • Aristada (aripiprazole lauroxil)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ribociclib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • rifabutin
  • Aristada (aripiprazole lauroxil)
    +
    rifabutin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + rifabutin

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • rifampin
  • Aristada (aripiprazole lauroxil)
    +
    rifampin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + rifampin

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • risperidone
  • Aristada (aripiprazole lauroxil)
    +
    risperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + risperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • ritonavir
  • Aristada (aripiprazole lauroxil)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ritonavir

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ropeginterferon alfa-2b
  • Aristada (aripiprazole lauroxil)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ropeginterferon alfa-2b

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • scopolamine
  • Aristada (aripiprazole lauroxil)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + scopolamine

    use alternative: combo may increase risk of CNS depression, psychomotor impairment, hyperthermia, including life-threatening (additive effects)

  • spironolactone
  • Aristada (aripiprazole lauroxil)
    +
    spironolactone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + spironolactone

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • St. John's wort
  • Aristada (aripiprazole lauroxil)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + St. John's wort

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, incr. aripiprazole lauroxil 441 mg qmo to 662 mg qmo; no dose adjustment at other doses: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • telmisartan
  • Aristada (aripiprazole lauroxil)
    +
    telmisartan
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + telmisartan

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • temazepam
  • Aristada (aripiprazole lauroxil)
    +
    temazepam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + temazepam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • terazosin
  • Aristada (aripiprazole lauroxil)
    +
    terazosin
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + terazosin

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbinafine
  • Aristada (aripiprazole lauroxil)
    +
    terbinafine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + terbinafine

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP3A4 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose or if CYP2D6 PM: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • thalidomide
  • Aristada (aripiprazole lauroxil)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + thalidomide

    use alternative or monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • timolol
  • Aristada (aripiprazole lauroxil)
    +
    timolol
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + timolol

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tipranavir
  • Aristada (aripiprazole lauroxil)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + tipranavir

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • torsemide
  • Aristada (aripiprazole lauroxil)
    +
    torsemide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + torsemide

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tradipitant
  • Aristada (aripiprazole lauroxil)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + tradipitant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • trandolapril
  • Aristada (aripiprazole lauroxil)
    +
    trandolapril
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + trandolapril

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tranylcypromine
  • Aristada (aripiprazole lauroxil)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + tranylcypromine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • triamterene
  • Aristada (aripiprazole lauroxil)
    +
    triamterene
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + triamterene

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • triazolam
  • Aristada (aripiprazole lauroxil)
    +
    triazolam
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + triazolam

    ARISTADA INITIO: avoid combo; ARISTADA: monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • trimethobenzamide
  • Aristada (aripiprazole lauroxil)
    +
    trimethobenzamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + trimethobenzamide

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • tucatinib
  • Aristada (aripiprazole lauroxil)
    +
    tucatinib
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + tucatinib

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • valsartan
  • Aristada (aripiprazole lauroxil)
    +
    valsartan
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + valsartan

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • verapamil
  • Aristada (aripiprazole lauroxil)
    +
    verapamil
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + verapamil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • voriconazole
  • Aristada (aripiprazole lauroxil)
    +
    voriconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + voriconazole

    ARISTADA INITIO: avoid combo; ARISTADA: if concurrent use >14 days, decr. aripiprazole lauroxil 1064 mg q2mo to 441 mg qmo, 882 mg q6wk to 441 mg qmo, 882 mg qmo to 662 mg qmo, 662 mg qmo to 441 mg qmo; if also CYP2D6 PM, decr. 1064 mg q2mo to 441 mg qmo, 882 mg qmo or q6wk to 441 mg qmo, 662 mg qmo to 441 mg qmo; if also combined w/ strong CYP2D6 inhibitor, avoid combo w/ 1064 mg, 882 mg, or 662 mg doses; no dose adjustment if on 441 mg dose: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ziprasidone
  • Aristada (aripiprazole lauroxil)
    +
    ziprasidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + ziprasidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • zuranolone
  • Aristada (aripiprazole lauroxil)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    aripiprazole lauroxil + zuranolone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

  • acarbose
  • Aristada (aripiprazole lauroxil)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alfentanil
  • Aristada (aripiprazole lauroxil)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + alfentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Aristada (aripiprazole lauroxil)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • alogliptin
  • Aristada (aripiprazole lauroxil)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Aristada (aripiprazole lauroxil)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

  • amantadine
  • Aristada (aripiprazole lauroxil)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + amantadine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Aristada (aripiprazole lauroxil)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • amitriptyline
  • Aristada (aripiprazole lauroxil)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + amitriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • amoxapine
  • Aristada (aripiprazole lauroxil)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + amoxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • apomorphine
  • Aristada (aripiprazole lauroxil)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + apomorphine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Aristada (aripiprazole lauroxil)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • articaine
  • Aristada (aripiprazole lauroxil)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • avanafil
  • Aristada (aripiprazole lauroxil)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • baclofen intrathecal
  • Aristada (aripiprazole lauroxil)
    +
    baclofen intrathecal
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + baclofen intrathecal

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • berberine
  • Aristada (aripiprazole lauroxil)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol ophthalmic
  • Aristada (aripiprazole lauroxil)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bethanechol
  • Aristada (aripiprazole lauroxil)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bexagliflozin
  • Aristada (aripiprazole lauroxil)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + bexagliflozin

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bortezomib
  • Aristada (aripiprazole lauroxil)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brimonidine ophthalmic
  • Aristada (aripiprazole lauroxil)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • brimonidine topical
  • Aristada (aripiprazole lauroxil)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + brimonidine topical

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Aristada (aripiprazole lauroxil)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bupivacaine
  • Aristada (aripiprazole lauroxil)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupivacaine liposomal
  • Aristada (aripiprazole lauroxil)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • buprenorphine
  • Aristada (aripiprazole lauroxil)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + buprenorphine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Aristada (aripiprazole lauroxil)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + butorphanol

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Aristada (aripiprazole lauroxil)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • canagliflozin
  • Aristada (aripiprazole lauroxil)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + canagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • cannabis
  • Aristada (aripiprazole lauroxil)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + cannabis

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • carteolol ophthalmic
  • Aristada (aripiprazole lauroxil)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chloroprocaine
  • Aristada (aripiprazole lauroxil)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorpromazine
  • Aristada (aripiprazole lauroxil)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + chlorpromazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • cilostazol
  • Aristada (aripiprazole lauroxil)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clofarabine
  • Aristada (aripiprazole lauroxil)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • clomipramine
  • Aristada (aripiprazole lauroxil)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + clomipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, seizures, hyperthermia, hypotension, including orthostasis (additive effects)

  • coenzyme Q-10
  • Aristada (aripiprazole lauroxil)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • colesevelam
  • Aristada (aripiprazole lauroxil)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dapagliflozin
  • Aristada (aripiprazole lauroxil)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dapagliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • daridorexant
  • Aristada (aripiprazole lauroxil)
    +
    daridorexant
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + daridorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • denileukin diftitox
  • Aristada (aripiprazole lauroxil)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Aristada (aripiprazole lauroxil)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + desflurane

    monitor respiratory rate, BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • desipramine
  • Aristada (aripiprazole lauroxil)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + desipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • dexmedetomidine
  • Aristada (aripiprazole lauroxil)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dexmedetomidine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Aristada (aripiprazole lauroxil)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dexmedetomidine injection

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe or life-threatening hypotension, including orthostasis (additive effects)

  • dihydrocodeine
  • Aristada (aripiprazole lauroxil)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dihydrocodeine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • dinutuximab
  • Aristada (aripiprazole lauroxil)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • dipyridamole
  • Aristada (aripiprazole lauroxil)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • doxepin
  • Aristada (aripiprazole lauroxil)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + doxepin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • dronabinol
  • Aristada (aripiprazole lauroxil)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dronabinol

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • droperidol
  • Aristada (aripiprazole lauroxil)
    +
    droperidol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + droperidol

    decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dulaglutide
  • Aristada (aripiprazole lauroxil)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Aristada (aripiprazole lauroxil)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + duloxetine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • empagliflozin
  • Aristada (aripiprazole lauroxil)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + empagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • entacapone
  • Aristada (aripiprazole lauroxil)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + entacapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Aristada (aripiprazole lauroxil)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + entrectinib

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • epoprostenol
  • Aristada (aripiprazole lauroxil)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ertugliflozin
  • Aristada (aripiprazole lauroxil)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ertugliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • esketamine
  • Aristada (aripiprazole lauroxil)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + esketamine

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • eszopiclone
  • Aristada (aripiprazole lauroxil)
    +
    eszopiclone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + eszopiclone

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ethanol (in some formulations)
  • Aristada (aripiprazole lauroxil)
    +
    ethanol (in some formulations)
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ethanol (in some formulations)

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etomidate
  • Aristada (aripiprazole lauroxil)
    +
    etomidate
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + etomidate

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etripamil nasal
  • Aristada (aripiprazole lauroxil)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • exenatide
  • Aristada (aripiprazole lauroxil)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fentanyl
  • Aristada (aripiprazole lauroxil)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + fentanyl

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Aristada (aripiprazole lauroxil)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flaxseed
  • Aristada (aripiprazole lauroxil)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flibanserin
  • Aristada (aripiprazole lauroxil)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + flibanserin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • fluphenazine
  • Aristada (aripiprazole lauroxil)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + fluphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis (additive effects)

  • fluvoxamine
  • Aristada (aripiprazole lauroxil)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + fluvoxamine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (additive effects)

  • foslevodopa
  • Aristada (aripiprazole lauroxil)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + foslevodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • gabapentin
  • Aristada (aripiprazole lauroxil)
    +
    gabapentin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + gabapentin

    monitor respiratory rate; consider decreasing gabapentin dose: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decrease seizure threshold)

  • gabapentin enacarbil
  • Aristada (aripiprazole lauroxil)
    +
    gabapentin enacarbil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + gabapentin enacarbil

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • garlic
  • Aristada (aripiprazole lauroxil)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • gilteritinib
  • Aristada (aripiprazole lauroxil)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ginkgo
  • Aristada (aripiprazole lauroxil)
    +
    ginkgo
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ginkgo

    monitor glucose: combo may incr. risk of hyperglycemia (additive effects)

  • glimepiride
  • Aristada (aripiprazole lauroxil)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Aristada (aripiprazole lauroxil)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Aristada (aripiprazole lauroxil)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Aristada (aripiprazole lauroxil)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + guanfacine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • hydromorphone
  • Aristada (aripiprazole lauroxil)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + hydromorphone

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxyzine
  • Aristada (aripiprazole lauroxil)
    +
    hydroxyzine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + hydroxyzine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ifosfamide
  • Aristada (aripiprazole lauroxil)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ifosfamide

    D/C one or both drugs if encephalopathy occurs; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • iloprost
  • Aristada (aripiprazole lauroxil)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Aristada (aripiprazole lauroxil)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + imipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • insulin
  • Aristada (aripiprazole lauroxil)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + insulin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • iohexol
  • Aristada (aripiprazole lauroxil)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + iohexol

    if intrathecal iohexol use, D/C aripiprazole lauroxil at least 48h before myelography, may resume at least 24h after procedure: combo may incr. risk of seizures (additive effects)

  • iopamidol
  • Aristada (aripiprazole lauroxil)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + iopamidol

    caution advised if intrathecal iopamidol use; consider holding aripiprazole lauroxil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • iron sucrose
  • Aristada (aripiprazole lauroxil)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isoflurane
  • Aristada (aripiprazole lauroxil)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + isoflurane

    monitor respiratory rate, BP: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • isosorbide dinitrate
  • Aristada (aripiprazole lauroxil)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Aristada (aripiprazole lauroxil)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ketamine
  • Aristada (aripiprazole lauroxil)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ketamine

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment (additive effects)

  • landiolol
  • Aristada (aripiprazole lauroxil)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lemborexant
  • Aristada (aripiprazole lauroxil)
    +
    lemborexant
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + lemborexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levobunolol ophthalmic
  • Aristada (aripiprazole lauroxil)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levodopa
  • Aristada (aripiprazole lauroxil)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + levodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • levorphanol
  • Aristada (aripiprazole lauroxil)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + levorphanol

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • lidocaine
  • Aristada (aripiprazole lauroxil)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • linagliptin
  • Aristada (aripiprazole lauroxil)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liraglutide
  • Aristada (aripiprazole lauroxil)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lithium
  • Aristada (aripiprazole lauroxil)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + lithium

    D/C one or both drugs if encephalopathy occurs: combo may incr. risk of encephalopathic syndrome, extrapyramidal symptoms (additive effects)

  • lixisenatide
  • Aristada (aripiprazole lauroxil)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lopinavir/ritonavir
  • Aristada (aripiprazole lauroxil)
    +
    lopinavir/ ritonavir
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + lopinavir/ ritonavir

    consider aripiprazole lauroxil dose adjustment: combo may incr. or decr. aripiprazole levels, incr. risk of adverse effects or decr. efficacy (hepatic metabolism altered)

  • loxapine
  • Aristada (aripiprazole lauroxil)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + loxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Aristada (aripiprazole lauroxil)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • magnesium sulfate
  • Aristada (aripiprazole lauroxil)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • maraviroc
  • Aristada (aripiprazole lauroxil)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meperidine
  • Aristada (aripiprazole lauroxil)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + meperidine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Aristada (aripiprazole lauroxil)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metformin
  • Aristada (aripiprazole lauroxil)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methadone
  • Aristada (aripiprazole lauroxil)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + methadone

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Aristada (aripiprazole lauroxil)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + methohexital

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Aristada (aripiprazole lauroxil)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • miglitol
  • Aristada (aripiprazole lauroxil)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milrinone
  • Aristada (aripiprazole lauroxil)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mirtazapine
  • Aristada (aripiprazole lauroxil)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + mirtazapine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • molindone
  • Aristada (aripiprazole lauroxil)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + molindone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension, including orthostasis (additive effects)

  • morphine
  • Aristada (aripiprazole lauroxil)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + morphine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nalbuphine
  • Aristada (aripiprazole lauroxil)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nalbuphine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Aristada (aripiprazole lauroxil)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Aristada (aripiprazole lauroxil)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • naxitamab
  • Aristada (aripiprazole lauroxil)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nelarabine
  • Aristada (aripiprazole lauroxil)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nelarabine

    withhold nelarabine if Grade 2 or greater somnolence occurs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • niacin (vitamin B3)
  • Aristada (aripiprazole lauroxil)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitric oxide
  • Aristada (aripiprazole lauroxil)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitrite
  • Aristada (aripiprazole lauroxil)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Aristada (aripiprazole lauroxil)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Aristada (aripiprazole lauroxil)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • nortriptyline
  • Aristada (aripiprazole lauroxil)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + nortriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Aristada (aripiprazole lauroxil)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oliceridine
  • Aristada (aripiprazole lauroxil)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + oliceridine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • opicapone
  • Aristada (aripiprazole lauroxil)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Aristada (aripiprazole lauroxil)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + opium

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxybutynin
  • Aristada (aripiprazole lauroxil)
    +
    oxybutynin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + oxybutynin

    decr. dose of one or both drugs or consider oxybutynin transdermal patch: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; somnolence less likely with oxybutynin transdermal patch (additive effects)

  • oxycodone
  • Aristada (aripiprazole lauroxil)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + oxycodone

    monitor BP, respiratory rate; decr. oxycodone start dose by at least 50%, consider decr. aripiprazole dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Aristada (aripiprazole lauroxil)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + oxymorphone

    monitor BP, respiratory rate; decr. oxymorphone start dose by at least 50%, consider decr. aripiprazole dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Aristada (aripiprazole lauroxil)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pentamidine
  • Aristada (aripiprazole lauroxil)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • pentazocine
  • Aristada (aripiprazole lauroxil)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + pentazocine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • perphenazine
  • Aristada (aripiprazole lauroxil)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + perphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, severe hypotension, including orthostasis, syncope (additive effects)

  • pioglitazone
  • Aristada (aripiprazole lauroxil)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pramipexole
  • Aristada (aripiprazole lauroxil)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + pramipexole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Aristada (aripiprazole lauroxil)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pregabalin
  • Aristada (aripiprazole lauroxil)
    +
    pregabalin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + pregabalin

    monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • procarbazine
  • Aristada (aripiprazole lauroxil)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + procarbazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • prochlorperazine
  • Aristada (aripiprazole lauroxil)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + prochlorperazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension, including orthostasis (additive effects)

  • propafenone
  • Aristada (aripiprazole lauroxil)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propofol
  • Aristada (aripiprazole lauroxil)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + propofol

    monitor respiratory rate, BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • protriptyline
  • Aristada (aripiprazole lauroxil)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + protriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • rasagiline
  • Aristada (aripiprazole lauroxil)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + rasagiline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • remifentanil
  • Aristada (aripiprazole lauroxil)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + remifentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • repaglinide
  • Aristada (aripiprazole lauroxil)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • riociguat
  • Aristada (aripiprazole lauroxil)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ropinirole
  • Aristada (aripiprazole lauroxil)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ropinirole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Aristada (aripiprazole lauroxil)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rosiglitazone
  • Aristada (aripiprazole lauroxil)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Aristada (aripiprazole lauroxil)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + rotigotine transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • sacubitril
  • Aristada (aripiprazole lauroxil)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Aristada (aripiprazole lauroxil)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + safinamide

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • saxagliptin
  • Aristada (aripiprazole lauroxil)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Aristada (aripiprazole lauroxil)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + selegiline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Aristada (aripiprazole lauroxil)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + selegiline transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • semaglutide
  • Aristada (aripiprazole lauroxil)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sevoflurane
  • Aristada (aripiprazole lauroxil)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sevoflurane

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • sildenafil
  • Aristada (aripiprazole lauroxil)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • silodosin
  • Aristada (aripiprazole lauroxil)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sitagliptin
  • Aristada (aripiprazole lauroxil)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium ferric gluconate complex
  • Aristada (aripiprazole lauroxil)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotagliflozin
  • Aristada (aripiprazole lauroxil)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Aristada (aripiprazole lauroxil)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sotalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sparsentan
  • Aristada (aripiprazole lauroxil)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sufentanil
  • Aristada (aripiprazole lauroxil)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + sufentanil

    monitor BP, respiratory rate; decr. sufentanil start dose, consider decr. aripiprazole dose, use lowest effective doses: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • suvorexant
  • Aristada (aripiprazole lauroxil)
    +
    suvorexant
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + suvorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tadalafil
  • Aristada (aripiprazole lauroxil)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tagraxofusp
  • Aristada (aripiprazole lauroxil)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tamsulosin
  • Aristada (aripiprazole lauroxil)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Aristada (aripiprazole lauroxil)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tapentadol

    monitor respiratory rate, BP; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Aristada (aripiprazole lauroxil)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Aristada (aripiprazole lauroxil)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + thioridazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • thiothixene
  • Aristada (aripiprazole lauroxil)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + thiothixene

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension, including orthostasis, syncope (additive effects)

  • timolol ophthalmic
  • Aristada (aripiprazole lauroxil)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tirzepatide
  • Aristada (aripiprazole lauroxil)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Aristada (aripiprazole lauroxil)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tizanidine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Aristada (aripiprazole lauroxil)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tolcapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tramadol
  • Aristada (aripiprazole lauroxil)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + tramadol

    monitor BP, respiratory rate, decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, seizures, severe hypotension, including orthostasis, syncope (additive effects)

  • trazodone
  • Aristada (aripiprazole lauroxil)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + trazodone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Aristada (aripiprazole lauroxil)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • trifluoperazine
  • Aristada (aripiprazole lauroxil)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + trifluoperazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Aristada (aripiprazole lauroxil)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + trimipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • vardenafil
  • Aristada (aripiprazole lauroxil)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vosoritide
  • Aristada (aripiprazole lauroxil)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • yohimbe
  • Aristada (aripiprazole lauroxil)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • zaleplon
  • Aristada (aripiprazole lauroxil)
    +
    zaleplon
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + zaleplon

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Aristada (aripiprazole lauroxil)
    +
    ziconotide
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + ziconotide

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolpidem
  • Aristada (aripiprazole lauroxil)
    +
    zolpidem
    1 interaction

    Monitor/Modify Tx

    aripiprazole lauroxil + zolpidem

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Caution Advised

  • 5-HTP
  • Aristada (aripiprazole lauroxil)
    +
    5-HTP
    1 interaction

    Caution Advised

    aripiprazole lauroxil + 5-HTP

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • acetazolamide
  • Aristada (aripiprazole lauroxil)
    +
    acetazolamide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + acetazolamide

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, aripiprazole may decr. seizure threshold)

  • aclidinium inhaled
  • Aristada (aripiprazole lauroxil)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    aripiprazole lauroxil + aclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • allopurinol
  • Aristada (aripiprazole lauroxil)
    +
    allopurinol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + allopurinol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • almotriptan
  • Aristada (aripiprazole lauroxil)
    +
    almotriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + almotriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • atropine
  • Aristada (aripiprazole lauroxil)
    +
    atropine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + atropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • baclofen
  • Aristada (aripiprazole lauroxil)
    +
    baclofen
    1 interaction

    Caution Advised

    aripiprazole lauroxil + baclofen

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • belladonna alkaloids
  • Aristada (aripiprazole lauroxil)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    aripiprazole lauroxil + belladonna alkaloids

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • benztropine
  • Aristada (aripiprazole lauroxil)
    +
    benztropine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + benztropine

    caution advised: combo may incr. risk of hyperthermia, including life-threatening (additive effects)

  • bosentan
  • Aristada (aripiprazole lauroxil)
    +
    bosentan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + bosentan

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • botulinum toxin
  • Aristada (aripiprazole lauroxil)
    +
    botulinum toxin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + botulinum toxin

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • brivaracetam
  • Aristada (aripiprazole lauroxil)
    +
    brivaracetam
    1 interaction

    Caution Advised

    aripiprazole lauroxil + brivaracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • brompheniramine
  • Aristada (aripiprazole lauroxil)
    +
    brompheniramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + brompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • buspirone
  • Aristada (aripiprazole lauroxil)
    +
    buspirone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + buspirone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • busulfan
  • Aristada (aripiprazole lauroxil)
    +
    busulfan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + busulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • cannabidiol
  • Aristada (aripiprazole lauroxil)
    +
    cannabidiol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + cannabidiol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • carbinoxamine
  • Aristada (aripiprazole lauroxil)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + carbinoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • carisoprodol
  • Aristada (aripiprazole lauroxil)
    +
    carisoprodol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + carisoprodol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cenobamate
  • Aristada (aripiprazole lauroxil)
    +
    cenobamate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + cenobamate

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • cetirizine
  • Aristada (aripiprazole lauroxil)
    +
    cetirizine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + cetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chamomile, German
  • Aristada (aripiprazole lauroxil)
    +
    chamomile, German
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chamomile, German

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chlophedianol
  • Aristada (aripiprazole lauroxil)
    +
    chlophedianol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chlophedianol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorambucil
  • Aristada (aripiprazole lauroxil)
    +
    chlorambucil
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chlorambucil

    caution advised: combo may incr. risk of seizures (additive effects)

  • chlorcyclizine
  • Aristada (aripiprazole lauroxil)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chlorcyclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chloroquine
  • Aristada (aripiprazole lauroxil)
    +
    chloroquine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chloroquine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • chlorpheniramine
  • Aristada (aripiprazole lauroxil)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorzoxazone
  • Aristada (aripiprazole lauroxil)
    +
    chlorzoxazone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + chlorzoxazone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • citalopram
  • Aristada (aripiprazole lauroxil)
    +
    citalopram
    1 interaction

    Caution Advised

    aripiprazole lauroxil + citalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • clemastine
  • Aristada (aripiprazole lauroxil)
    +
    clemastine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + clemastine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • clidinium
  • Aristada (aripiprazole lauroxil)
    +
    clidinium
    1 interaction

    Caution Advised

    aripiprazole lauroxil + clidinium

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • cyclobenzaprine
  • Aristada (aripiprazole lauroxil)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + cyclobenzaprine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • cyproheptadine
  • Aristada (aripiprazole lauroxil)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + cyproheptadine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dabrafenib
  • Aristada (aripiprazole lauroxil)
    +
    dabrafenib
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dabrafenib

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • dantrolene
  • Aristada (aripiprazole lauroxil)
    +
    dantrolene
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dantrolene

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Aristada (aripiprazole lauroxil)
    +
    darifenacin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + darifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • desvenlafaxine
  • Aristada (aripiprazole lauroxil)
    +
    desvenlafaxine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + desvenlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • deutetrabenazine
  • Aristada (aripiprazole lauroxil)
    +
    deutetrabenazine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + deutetrabenazine

    caution advised: combo may incr. risk of neuroleptic malignant syndrome, extrapyramidal symptoms, CNS depression, psychomotor impairment (additive effects)

  • dexbrompheniramine
  • Aristada (aripiprazole lauroxil)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dexbrompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dexchlorpheniramine
  • Aristada (aripiprazole lauroxil)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dexchlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dichlorphenamide
  • Aristada (aripiprazole lauroxil)
    +
    dichlorphenamide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dichlorphenamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dicyclomine
  • Aristada (aripiprazole lauroxil)
    +
    dicyclomine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dicyclomine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • difelikefalin
  • Aristada (aripiprazole lauroxil)
    +
    difelikefalin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + difelikefalin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Aristada (aripiprazole lauroxil)
    +
    difenoxin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + difenoxin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dimenhydrinate
  • Aristada (aripiprazole lauroxil)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + dimenhydrinate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenhydramine
  • Aristada (aripiprazole lauroxil)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + diphenhydramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenoxylate
  • Aristada (aripiprazole lauroxil)
    +
    diphenoxylate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + diphenoxylate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • disopyramide
  • Aristada (aripiprazole lauroxil)
    +
    disopyramide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + disopyramide

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • domperidone
  • Aristada (aripiprazole lauroxil)
    +
    domperidone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + domperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • doxepin topical
  • Aristada (aripiprazole lauroxil)
    +
    doxepin topical
    1 interaction

    Caution Advised

    aripiprazole lauroxil + doxepin topical

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • efavirenz
  • Aristada (aripiprazole lauroxil)
    +
    efavirenz
    1 interaction

    Caution Advised

    aripiprazole lauroxil + efavirenz

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • eletriptan
  • Aristada (aripiprazole lauroxil)
    +
    eletriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + eletriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Aristada (aripiprazole lauroxil)
    +
    elinzanetant
    1 interaction

    Caution Advised

    aripiprazole lauroxil + elinzanetant

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • escitalopram
  • Aristada (aripiprazole lauroxil)
    +
    escitalopram
    1 interaction

    Caution Advised

    aripiprazole lauroxil + escitalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • eslicarbazepine acetate
  • Aristada (aripiprazole lauroxil)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + eslicarbazepine acetate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • ethosuximide
  • Aristada (aripiprazole lauroxil)
    +
    ethosuximide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + ethosuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • etravirine
  • Aristada (aripiprazole lauroxil)
    +
    etravirine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + etravirine

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • felbamate
  • Aristada (aripiprazole lauroxil)
    +
    felbamate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + felbamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • fenfluramine
  • Aristada (aripiprazole lauroxil)
    +
    fenfluramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + fenfluramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • fesoterodine
  • Aristada (aripiprazole lauroxil)
    +
    fesoterodine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + fesoterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • fexinidazole
  • Aristada (aripiprazole lauroxil)
    +
    fexinidazole
    1 interaction

    Caution Advised

    aripiprazole lauroxil + fexinidazole

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • flavoxate
  • Aristada (aripiprazole lauroxil)
    +
    flavoxate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + flavoxate

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • frovatriptan
  • Aristada (aripiprazole lauroxil)
    +
    frovatriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + frovatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • galantamine
  • Aristada (aripiprazole lauroxil)
    +
    galantamine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + galantamine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • ganaxolone
  • Aristada (aripiprazole lauroxil)
    +
    ganaxolone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + ganaxolone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • glofitamab
  • Aristada (aripiprazole lauroxil)
    +
    glofitamab
    1 interaction

    Caution Advised

    aripiprazole lauroxil + glofitamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate
  • Aristada (aripiprazole lauroxil)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + glycopyrrolate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • glycopyrrolate inhaled
  • Aristada (aripiprazole lauroxil)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    aripiprazole lauroxil + glycopyrrolate inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • glycopyrronium topical
  • Aristada (aripiprazole lauroxil)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    aripiprazole lauroxil + glycopyrronium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • homatropine
  • Aristada (aripiprazole lauroxil)
    +
    homatropine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + homatropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • hydroxychloroquine
  • Aristada (aripiprazole lauroxil)
    +
    hydroxychloroquine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + hydroxychloroquine

    caution advised: combo may incr. risk of seizures (additive effects)

  • hyoscyamine
  • Aristada (aripiprazole lauroxil)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + hyoscyamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ipratropium inhaled
  • Aristada (aripiprazole lauroxil)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    aripiprazole lauroxil + ipratropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • lacosamide
  • Aristada (aripiprazole lauroxil)
    +
    lacosamide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + lacosamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • lamotrigine
  • Aristada (aripiprazole lauroxil)
    +
    lamotrigine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + lamotrigine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • levetiracetam
  • Aristada (aripiprazole lauroxil)
    +
    levetiracetam
    1 interaction

    Caution Advised

    aripiprazole lauroxil + levetiracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • levocetirizine
  • Aristada (aripiprazole lauroxil)
    +
    levocetirizine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + levocetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levomilnacipran
  • Aristada (aripiprazole lauroxil)
    +
    levomilnacipran
    1 interaction

    Caution Advised

    aripiprazole lauroxil + levomilnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • linvoseltamab
  • Aristada (aripiprazole lauroxil)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    aripiprazole lauroxil + linvoseltamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lorlatinib
  • Aristada (aripiprazole lauroxil)
    +
    lorlatinib
    1 interaction

    Caution Advised

    aripiprazole lauroxil + lorlatinib

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • magnesium citrate
  • Aristada (aripiprazole lauroxil)
    +
    magnesium citrate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + magnesium citrate

    caution advised, especially if magnesium citrate bowel prep use: combo may incr. risk of seizures (additive effects)

  • mavacamten
  • Aristada (aripiprazole lauroxil)
    +
    mavacamten
    1 interaction

    Caution Advised

    aripiprazole lauroxil + mavacamten

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • meclizine
  • Aristada (aripiprazole lauroxil)
    +
    meclizine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + meclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • melatonin
  • Aristada (aripiprazole lauroxil)
    +
    melatonin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + melatonin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meprobamate
  • Aristada (aripiprazole lauroxil)
    +
    meprobamate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + meprobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methocarbamol
  • Aristada (aripiprazole lauroxil)
    +
    methocarbamol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + methocarbamol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methscopolamine
  • Aristada (aripiprazole lauroxil)
    +
    methscopolamine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + methscopolamine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • methsuximide
  • Aristada (aripiprazole lauroxil)
    +
    methsuximide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + methsuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • metyrapone
  • Aristada (aripiprazole lauroxil)
    +
    metyrapone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + metyrapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Aristada (aripiprazole lauroxil)
    +
    metyrosine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + metyrosine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • milnacipran
  • Aristada (aripiprazole lauroxil)
    +
    milnacipran
    1 interaction

    Caution Advised

    aripiprazole lauroxil + milnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mitapivat
  • Aristada (aripiprazole lauroxil)
    +
    mitapivat
    1 interaction

    Caution Advised

    aripiprazole lauroxil + mitapivat

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • modafinil
  • Aristada (aripiprazole lauroxil)
    +
    modafinil
    1 interaction

    Caution Advised

    aripiprazole lauroxil + modafinil

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • mosunetuzumab
  • Aristada (aripiprazole lauroxil)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    aripiprazole lauroxil + mosunetuzumab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Aristada (aripiprazole lauroxil)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    aripiprazole lauroxil + mycophenolate mofetil

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nafcillin
  • Aristada (aripiprazole lauroxil)
    +
    nafcillin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + nafcillin

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • naltrexone
  • Aristada (aripiprazole lauroxil)
    +
    naltrexone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + naltrexone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naratriptan
  • Aristada (aripiprazole lauroxil)
    +
    naratriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + naratriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • orphenadrine
  • Aristada (aripiprazole lauroxil)
    +
    orphenadrine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + orphenadrine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • oxcarbazepine
  • Aristada (aripiprazole lauroxil)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + oxcarbazepine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • pacritinib
  • Aristada (aripiprazole lauroxil)
    +
    pacritinib
    1 interaction

    Caution Advised

    aripiprazole lauroxil + pacritinib

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • passion flower
  • Aristada (aripiprazole lauroxil)
    +
    passion flower
    1 interaction

    Caution Advised

    aripiprazole lauroxil + passion flower

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • perampanel
  • Aristada (aripiprazole lauroxil)
    +
    perampanel
    1 interaction

    Caution Advised

    aripiprazole lauroxil + perampanel

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • pexidartinib
  • Aristada (aripiprazole lauroxil)
    +
    pexidartinib
    1 interaction

    Caution Advised

    aripiprazole lauroxil + pexidartinib

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • pheniramine
  • Aristada (aripiprazole lauroxil)
    +
    pheniramine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + pheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • pimozide
  • Aristada (aripiprazole lauroxil)
    +
    pimozide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + pimozide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms (additive effects)

  • polyethylene glycol
  • Aristada (aripiprazole lauroxil)
    +
    polyethylene glycol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + polyethylene glycol

    caution advised, especially if polyethylene glycol bowel prep use: combo may incr. risk of seizures (additive effects)

  • polyethylene glycol/electrolytes
  • Aristada (aripiprazole lauroxil)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Caution Advised

    aripiprazole lauroxil + polyethylene glycol/ electrolytes

    caution advised: combo may incr. risk of seizures (additive effects)

  • pyrilamine
  • Aristada (aripiprazole lauroxil)
    +
    pyrilamine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + pyrilamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ramelteon
  • Aristada (aripiprazole lauroxil)
    +
    ramelteon
    1 interaction

    Caution Advised

    aripiprazole lauroxil + ramelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • repotrectinib
  • Aristada (aripiprazole lauroxil)
    +
    repotrectinib
    1 interaction

    Caution Advised

    aripiprazole lauroxil + repotrectinib

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • revefenacin inhaled
  • Aristada (aripiprazole lauroxil)
    +
    revefenacin inhaled
    1 interaction

    Caution Advised

    aripiprazole lauroxil + revefenacin inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • rifapentine
  • Aristada (aripiprazole lauroxil)
    +
    rifapentine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + rifapentine

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • rivastigmine
  • Aristada (aripiprazole lauroxil)
    +
    rivastigmine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + rivastigmine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • rizatriptan
  • Aristada (aripiprazole lauroxil)
    +
    rizatriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + rizatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rufinamide
  • Aristada (aripiprazole lauroxil)
    +
    rufinamide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + rufinamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • selinexor
  • Aristada (aripiprazole lauroxil)
    +
    selinexor
    1 interaction

    Caution Advised

    aripiprazole lauroxil + selinexor

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sertraline
  • Aristada (aripiprazole lauroxil)
    +
    sertraline
    1 interaction

    Caution Advised

    aripiprazole lauroxil + sertraline

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sodium picosulfate
  • Aristada (aripiprazole lauroxil)
    +
    sodium picosulfate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + sodium picosulfate

    caution advised: combo may incr. risk of seizures (additive effects)

  • sofpironium topical
  • Aristada (aripiprazole lauroxil)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    aripiprazole lauroxil + sofpironium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • solifenacin
  • Aristada (aripiprazole lauroxil)
    +
    solifenacin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + solifenacin

    caution advised: combo may incr. risk of hyperthermia, CNS depression, psychomotor impairment (additive effects)

  • sotorasib
  • Aristada (aripiprazole lauroxil)
    +
    sotorasib
    1 interaction

    Caution Advised

    aripiprazole lauroxil + sotorasib

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • stiripentol
  • Aristada (aripiprazole lauroxil)
    +
    stiripentol
    1 interaction

    Caution Advised

    aripiprazole lauroxil + stiripentol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • sulfate bowel prep
  • Aristada (aripiprazole lauroxil)
    +
    sulfate bowel prep
    1 interaction

    Caution Advised

    aripiprazole lauroxil + sulfate bowel prep

    caution advised: combo may incr. risk of seizures (additive effects)

  • sumatriptan
  • Aristada (aripiprazole lauroxil)
    +
    sumatriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + sumatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tasimelteon
  • Aristada (aripiprazole lauroxil)
    +
    tasimelteon
    1 interaction

    Caution Advised

    aripiprazole lauroxil + tasimelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tetrabenazine
  • Aristada (aripiprazole lauroxil)
    +
    tetrabenazine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + tetrabenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thiotepa
  • Aristada (aripiprazole lauroxil)
    +
    thiotepa
    1 interaction

    Caution Advised

    aripiprazole lauroxil + thiotepa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tiagabine
  • Aristada (aripiprazole lauroxil)
    +
    tiagabine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + tiagabine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • tiotropium inhaled
  • Aristada (aripiprazole lauroxil)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    aripiprazole lauroxil + tiotropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • tolterodine
  • Aristada (aripiprazole lauroxil)
    +
    tolterodine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + tolterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • topiramate
  • Aristada (aripiprazole lauroxil)
    +
    topiramate
    1 interaction

    Caution Advised

    aripiprazole lauroxil + topiramate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • treosulfan
  • Aristada (aripiprazole lauroxil)
    +
    treosulfan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + treosulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • trihexyphenidyl
  • Aristada (aripiprazole lauroxil)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    aripiprazole lauroxil + trihexyphenidyl

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • triprolidine
  • Aristada (aripiprazole lauroxil)
    +
    triprolidine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + triprolidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • trospium
  • Aristada (aripiprazole lauroxil)
    +
    trospium
    1 interaction

    Caution Advised

    aripiprazole lauroxil + trospium

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • umeclidinium inhaled
  • Aristada (aripiprazole lauroxil)
    +
    umeclidinium inhaled
    1 interaction

    Caution Advised

    aripiprazole lauroxil + umeclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • valbenazine
  • Aristada (aripiprazole lauroxil)
    +
    valbenazine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + valbenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valerian
  • Aristada (aripiprazole lauroxil)
    +
    valerian
    1 interaction

    Caution Advised

    aripiprazole lauroxil + valerian

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Aristada (aripiprazole lauroxil)
    +
    valproic acid
    1 interaction

    Caution Advised

    aripiprazole lauroxil + valproic acid

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • venlafaxine
  • Aristada (aripiprazole lauroxil)
    +
    venlafaxine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + venlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • vigabatrin
  • Aristada (aripiprazole lauroxil)
    +
    vigabatrin
    1 interaction

    Caution Advised

    aripiprazole lauroxil + vigabatrin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • vilazodone
  • Aristada (aripiprazole lauroxil)
    +
    vilazodone
    1 interaction

    Caution Advised

    aripiprazole lauroxil + vilazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • viloxazine
  • Aristada (aripiprazole lauroxil)
    +
    viloxazine
    1 interaction

    Caution Advised

    aripiprazole lauroxil + viloxazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolmitriptan
  • Aristada (aripiprazole lauroxil)
    +
    zolmitriptan
    1 interaction

    Caution Advised

    aripiprazole lauroxil + zolmitriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Aristada (aripiprazole lauroxil)
    +
    zonisamide
    1 interaction

    Caution Advised

    aripiprazole lauroxil + zonisamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@5ebfb31b
  • hypersensitivity reaction
  • anaphylaxis
  • drug reaction with eosinophilia and systemic symptoms
  • neuroleptic malignant syndrome
  • extrapyramidal symptoms
  • tardive dyskinesia
  • dystonia
  • stroke
  • TIA
  • syncope
  • hypotension, orthostatic
  • seizures
  • hyperglycemia
  • diabetes mellitus
  • dysphagia, severe
  • aspiration
  • hyperthermia
  • hypothermia
  • pancreatitis
  • blood dyscrasia
  • leukopenia
  • neutropenia
  • agranulocytosis
  • rhabdomyolysis
  • suicidality
  • depression exacerbation

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@69da4067
  • akathisia
  • weight gain
  • headache
  • injection site reaction
  • insomnia
  • parkinsonism
  • restlessness
  • dystonia
  • CPK incr.
  • anxiety
  • dizziness
  • constipation
  • xerostomia
  • dyslipidemia
  • hyperglycemia
  • impaired body temperature regulation
  • compulsive behaviors

Safety/Monitoring .

Monitoring Parameters
fasting glucose at baseline if diabetes risk factors, then periodically; CBC with diff frequently during initial tx if pre-existing or history of leukopenia/neutropenia; weight; consider orthostatic vital signs if hypotension risk

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 3rd trimester; risk of teratogenicity not expected based on limited human data, though risk of neonatal extrapyramidal and withdrawal symptoms based on human data with antipsychotics

Pregnancy Registry

encourage patients to enroll in National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding, monitor infant for dehydration and poor wt. gain; possible risk of infant harm based on limited human data; decr. milk production based on human data and decr. prolactin levels

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@5187a189

Metabolism: for aripiprazole lauroxil: liver; CYP450: 2D6, 3A4 substrate

Excretion: for aripiprazole lauroxil: feces 55% (18% unchanged), urine 25% (<1% unchanged); Half-life: 53.9-57.2 days

Subclass: Antipsychotics, 2nd generation

Mechanism of Action
for aripiprazole lauroxil: prodrug converted to aripiprazole; exact mechanism of action unknown; partially agonizes dopamine D2 and serotonin 5-HT1A receptors, antagonizes serotonin 5-HT2A receptors

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Alkermes, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@28eb3671

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

intramuscular suspension, extended release:

  • 441 mg (1 syringe, 1.6 mL): $1,452.00

intramuscular suspension, extended release:

  • 662 mg (1 syringe, 2.4 mL): $2,174.00

intramuscular suspension, extended release:

  • 882 mg (1 syringe, 3.2 mL): $2,893.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information